Creo Medical Group (CREO.LSE) Q3 2024 Earnings

30SepConfirmed
Q1 2023
Q2 2023
Q2 2024
Q3 2024
-2.84
-2.5
-2.17
-1.84

Details

Expected EPS
N/A
Actual EPS
-2.83557204
Surprise EPS
-2.84
Surprise Percent
+∞%

Description

Creo Medical Group (CREO.LSE) has reported earnings of -2.83557204 per share for Q3 2024.

0 Comments

Share your thoughts